5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Condition: Tobacco Use Disorder Interventions: Drug: Psilocybin; Drug: Niacin Sponsors: Johns Hopkins University; University of Alabama at Birmingham; New York University; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials
Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis
Conditions: Periodontitis Stage I; Periodontal Diseases; Periodontal Inflammation; Periodontal Attachment Loss; Periodontitis; Periodontitis Stage II Interventions: Drug: Vitamin B3 100 MG Oral Tablet; Drug: vitamin B9; Drug: Placebo; Procedure: full mouth non surgical periodontal treatment Sponsor: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2022 Category: Research Source Type: clinical trials